Blocking TMEM141 Reduces MASH and Fibrosis Through ROS-HNF4α Pathway
A groundbreaking study has unveiled a promising therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, two increasingly prevalent ...
A groundbreaking study has unveiled a promising therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, two increasingly prevalent ...
In a groundbreaking study poised to reshape our understanding of liver metabolism and cellular stress response, researchers have unveiled the ...
In a groundbreaking development that promises to reshape our understanding of metabolic disorders and fibrotic diseases, researchers have unveiled the ...
In a groundbreaking study published in Nature Communications, researchers have unveiled a novel mechanistic link between the pathogenic bacterium Helicobacter ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine